Cannabis Use Disorder: Update amidst the COVID-19 Pandemic

CME Educational Session with Discussion

Zoom Webinar • Thursday, November 19, 6:30-7:30 PM

The COVID-19 pandemic has posed unique challenges for addiction treatment across Maryland and DC. In the final installment of this three part CME series, we will focus on key principles and best practices for the treatment of cannabis use disorder during the pandemic.

Participants in this educational session will be able to:

  • Be familiar with the latest epidemiological data on cannabis use disorder
  • Recognize the major adverse consequences of cannabis use disorder
  • Understand the use of psychosocial approaches in the treatment of cannabis use disorder

After the close of this session at 7:30 PM, attendees are encouraged to stay on the line for virtual discussion in small breakout groups. 


AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1 AMA PRA Category 1 Credits™ available for each date: September 22, October 22 and November 19.

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The MD/DCSAM Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Did you miss part one of this series? You can view clips from the last event on our YouTube channel and review each presenters' slide deck below: